...
search icon
life-img

aTyr Pharma Inc Share Price

LIFE
NSQ
$10.558
+$0.27
(2.62%)
1D
Industry: Biotechnology Sector: Health Care

aTyr Pharma Inc Analyst Forecast

aTyr Pharma Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$646.33M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
50.22K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.19

About aTyr Pharma Inc, Common Stock

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

aTyr Pharma Inc Stock Returns

Time FrameLIFESectorS&P500
1-Week Return--0.03%-1.31%
1-Month Return-0.59%-1.75%
3-Month Return-3.23%1.44%
6-Month Return-18.29%5.74%
1-Year Return-7.71%11.81%
3-Year Return367.73%18.03%65.25%
5-Year Return67.05%35.78%73.79%
10-Year Return-83.03%140.42%260.26%

aTyr Pharma Inc Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue422.00K10.46M10.75K10.39M353.00K[{"date":"2019-12-31","value":4.04,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":0.1,"profit":true},{"date":"2022-12-31","value":99.34,"profit":true},{"date":"2023-12-31","value":3.38,"profit":true}]
Cost of Revenue14.05M17.29M1.30M1.70M2.74M[{"date":"2019-12-31","value":81.24,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":7.54,"profit":true},{"date":"2022-12-31","value":9.8,"profit":true},{"date":"2023-12-31","value":15.85,"profit":true}]
Gross Profit422.00K10.46M(1.30M)10.39M(2.39M)[{"date":"2019-12-31","value":4.04,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-12.47,"profit":false},{"date":"2022-12-31","value":99.34,"profit":true},{"date":"2023-12-31","value":-22.84,"profit":false}]
Gross Margin100.00%100.00%(12129.10%)100.00%(676.49%)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-12129.1,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-676.49,"profit":false}]
Operating Expenses23.40M26.37M34.02M56.79M52.53M[{"date":"2019-12-31","value":41.2,"profit":true},{"date":"2020-12-31","value":46.43,"profit":true},{"date":"2021-12-31","value":59.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.5,"profit":true}]
Operating Income(22.98M)(15.91M)(34.02M)(46.40M)(54.92M)[{"date":"2019-12-31","value":-2297800000,"profit":false},{"date":"2020-12-31","value":-1591100000,"profit":false},{"date":"2021-12-31","value":-3401500000,"profit":false},{"date":"2022-12-31","value":-4640400000,"profit":false},{"date":"2023-12-31","value":-5491900000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(23.76M)(16.23M)(33.78M)(45.34M)(50.40M)[{"date":"2019-12-31","value":-2376300000,"profit":false},{"date":"2020-12-31","value":-1623000000,"profit":false},{"date":"2021-12-31","value":-3377700000,"profit":false},{"date":"2022-12-31","value":-4534300000,"profit":false},{"date":"2023-12-31","value":-5039700000,"profit":false}]
Income Taxes(1.53M)(1.27M)(1.31M)(1.07M)(8.00K)[{"date":"2019-12-31","value":-152600000,"profit":false},{"date":"2020-12-31","value":-127200000,"profit":false},{"date":"2021-12-31","value":-131300000,"profit":false},{"date":"2022-12-31","value":-106600000,"profit":false},{"date":"2023-12-31","value":-800000,"profit":false}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(23.76M)(16.23M)(33.78M)(45.34M)(43.16M)[{"date":"2019-12-31","value":-2376300000,"profit":false},{"date":"2020-12-31","value":-1623000000,"profit":false},{"date":"2021-12-31","value":-3377700000,"profit":false},{"date":"2022-12-31","value":-4534300000,"profit":false},{"date":"2023-12-31","value":-4315900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(22.24M)(14.96M)(32.46M)(44.28M)(50.39M)[{"date":"2019-12-31","value":-2223700000,"profit":false},{"date":"2020-12-31","value":-1495800000,"profit":false},{"date":"2021-12-31","value":-3246400000,"profit":false},{"date":"2022-12-31","value":-4427700000,"profit":false},{"date":"2023-12-31","value":-5038900000,"profit":false}]
EPS (Diluted)(7.33)(1.59)(1.88)(1.60)(0.96)[{"date":"2019-12-31","value":-733,"profit":false},{"date":"2020-12-31","value":-159,"profit":false},{"date":"2021-12-31","value":-188,"profit":false},{"date":"2022-12-31","value":-160,"profit":false},{"date":"2023-12-31","value":-96,"profit":false}]

aTyr Pharma Inc Ratios

aTyr Pharma Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

LIFE
Cash Ratio 5.29
Current Ratio 6.07

aTyr Pharma Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LIFE
ROA (LTM) -29.37%
ROE (LTM) -55.61%

aTyr Pharma Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LIFE
Debt Ratio Lower is generally better. Negative is bad. 0.26
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.75

aTyr Pharma Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LIFE
Trailing PE NM
Forward PE NM
P/S (TTM) 334.89
P/B 1.30
Price/FCF NM
EV/R 99.56
EV/Ebitda NM
PEG NM

FAQs

What is aTyr Pharma Inc share price today?

aTyr Pharma Inc (LIFE) share price today is $10.558

Can Indians buy aTyr Pharma Inc shares?

Yes, Indians can buy shares of aTyr Pharma Inc (LIFE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LIFE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of aTyr Pharma Inc be purchased?

Yes, you can purchase fractional shares of aTyr Pharma Inc (LIFE) via the Vested app. You can start investing in aTyr Pharma Inc (LIFE) with a minimum investment of $1.

How to invest in aTyr Pharma Inc shares from India?

You can invest in shares of aTyr Pharma Inc (LIFE) via Vested in three simple steps:

  • Click on Sign Up or Invest in LIFE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in aTyr Pharma Inc shares
What is aTyr Pharma Inc 52-week high and low stock price?

The 52-week high price of aTyr Pharma Inc (LIFE) is $. The 52-week low price of aTyr Pharma Inc (LIFE) is $.

What is aTyr Pharma Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of aTyr Pharma Inc (LIFE) is

What is aTyr Pharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of aTyr Pharma Inc (LIFE) is 1.30

What is aTyr Pharma Inc dividend yield?

The dividend yield of aTyr Pharma Inc (LIFE) is 0.00%

What is the Market Cap of aTyr Pharma Inc?

The market capitalization of aTyr Pharma Inc (LIFE) is $646.33M

What is aTyr Pharma Inc's stock symbol?

The stock symbol (or ticker) of aTyr Pharma Inc is LIFE

How Can Investors Use aTyr Pharma Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of aTyr Pharma Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether aTyr Pharma Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from aTyr Pharma Inc shares for Indian investors?

When investing in aTyr Pharma Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the aTyr Pharma Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare aTyr Pharma Inc share price with other stocks in the same sector?

Rather than merely checking the share price of aTyr Pharma Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that aTyr Pharma Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top